1.42
-0.02(-1.39%)
Currency In USD
| Previous Close | 1.44 |
| Open | 1.44 |
| Day High | 1.51 |
| Day Low | 1.38 |
| 52-Week High | 10.2 |
| 52-Week Low | 1.26 |
| Volume | 35,706 |
| Average Volume | 2.52M |
| Market Cap | 2.58M |
| PE | 0.01 |
| EPS | 164.37 |
| Moving Average 50 Days | 1.95 |
| Moving Average 200 Days | 2.24 |
| Change | -0.02 |
If you invested $1000 in Bluejay Diagnostics, Inc. (BJDX) since IPO date, it would be worth $0.03 as of November 19, 2025 at a share price of $1.42. Whereas If you bought $1000 worth of Bluejay Diagnostics, Inc. (BJDX) shares 3 years ago, it would be worth $0.26 as of November 19, 2025 at a share price of $1.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
GlobeNewswire Inc.
Nov 10, 2025 12:30 PM GMT
Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization.Patient enrollment in SYMON-II clinical trial now approximately 50% completed.Recent p
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 10, 2025 9:16 PM GMT
ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced the closing of its previously
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 09, 2025 7:15 PM GMT
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into defin